Skip to content

Author

M. R. Shakhgireeva

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Efficacy and safety of pathogenetic therapy for cystic fibrosis in children in the Chechen Republic: Use of a generic CFTR modulator and experience of switching within a same international non-proprietary name

The use of both the original drug and generic Trilexa in children with CF is associated with clinical improvements in key efficacy indicators and a favorable safety profile.

M. R. Shakhgireeva, A. Ibisheva, A. B. Khildikharoeva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.